Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

MHRA grants early access to lumasiran in the U.K.

July 14, 2020

Phase II study of CS-02 meets primary endpoint

July 13, 2020

Macrophage crosstalk inflames fat

July 10, 2020

Phase III data on Yselty in uterine fibroids support progression to regulatory filings

July 6, 2020

European Commission approves canagliflozin label update

July 2, 2020

Machine learning, GWAS divide and conquer PCOS

July 2, 2020

Placental attachment theory

July 2, 2020

FDA approves Dojolvi for long-chain fatty acid oxidation disorders

July 1, 2020

Shanghai Jemincare Pharmaceuticals, Jiangxi Jemincare Group disclose S1P1 agonists

July 1, 2020

Preclinical studies show promise of GLP-1R agonist GL-0034 for treating diabetes

July 1, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 6, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Regulatory actions for May 5, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Adma, Applied...